FAM
ABMD

Fred Alger Management’s Abiomed Inc ABMD Stock Holding History

Fred Alger Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-253
Closed -$62K – 580
2022
Q3 		$62K Hold
253
– – ﹤0.01% 447
2022
Q2 		$63K Sell
253
-7,821
-97% -$2.11M ﹤0.01% 455
2022
Q1 		$2.67M Sell
8,074
-4,613
-36% -$1.42M 0.01% 322
2021
Q4 		$4.56M Sell
12,687
-3,505
-22% -$1.18M 0.01% 309
2021
Q3 		$5.27M Buy
16,192
+8,730
+117% +$2.96M 0.01% 286
2021
Q2 		$2.33M Sell
7,462
-57,967
-89% -$17.8M 0.01% 344
2021
Q1 		$20.9M Sell
65,429
-506,098
-89% -$162M 0.05% 198
2020
Q4 		$185M Buy
571,527
+1,593
+0.3% +$441K 0.48% 59
2020
Q3 		$158M Sell
569,934
-48,907
-8% -$14.1M 0.46% 61
2020
Q2 		$149M Buy
618,841
+61,329
+11% +$12.3M 0.49% 53
2020
Q1 		$80.9M Buy
557,512
+68,001
+14% +$11.3M 0.36% 68
2019
Q4 		$83.5M Sell
489,511
-48,469
-9% -$8.99M 0.31% 90
2019
Q3 		$95.7M Sell
537,980
-22,509
-4% -$4.87M 0.38% 69
2019
Q2 		$146M Buy
560,489
+129,359
+30% +$34.3M 0.56% 48
2019
Q1 		$123M Sell
431,130
-159,004
-27% -$52.8M 0.49% 52
2018
Q4 		$192M Buy
590,134
+32,428
+6% +$11.3M 0.88% 25
2018
Q3 		$251M Buy
557,706
+173,466
+45% +$68.4M 0.94% 26
2018
Q2 		$157M Sell
384,240
-4,291
-1% -$1.55M 0.66% 36
2018
Q1 		$113M Sell
388,531
-110,763
-22% -$28.1M 0.53% 45
2017
Q4 		$93.6M Buy
499,294
+121,810
+32% +$22.7M 0.42% 57
2017
Q3 		$63.6M Buy
377,484
+123,654
+49% +$18.7M 0.3% 80
2017
Q2 		$36.4M Sell
253,830
-13,914
-5% -$1.87M 0.17% 104
2017
Q1 		$33.5M Buy
267,744
+15,956
+6% +$1.85M 0.17% 101
2016
Q4 		$28.4M Buy
251,788
+57,979
+30% +$6.72M 0.15% 102
2016
Q3 		$24.9M Sell
193,809
-31,135
-14% -$3.73M 0.13% 112
2016
Q2 		$24.6M Buy
224,944
+10,034
+5% +$998K 0.13% 122
2016
Q1 		$20.4M Sell
214,910
-7,556
-3% -$638K 0.1% 139
2015
Q4 		$20.1M Sell
222,466
-1,385
-0.6% -$118K 0.1% 120
2015
Q3 		$20.8M Sell
223,851
-3,865
-2% -$341K 0.11% 120
2015
Q2 		$15M Buy
227,716
+214,166
+1,581% +$14.2M 0.07% 176
2015
Q1 		$970K Buy
+13,550
New +$735K ﹤0.01% 503

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fred Alger Management's ABMD Position: Q4 2022 in Review

Fred Alger Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 253 shares — an estimated $62K sold.

Fred Alger Management first reported a position in ABMD in Q1 2015 and held it in 31 quarters. The position peaked at $251M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Fred Alger Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Fred Alger Management sold 253 Abiomed Inc shares in Q4 2022, an estimated $62K.
  • Fred Alger Management first reported a position in Abiomed Inc in Q1 2015 and held it in 31 quarters.
  • Fred Alger Management's Abiomed Inc position peaked at $251M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Fred Alger Management's 13F filing for Q4 2022, filed 14 Feb 2023.